Medivir Presents at the Rodman & Renshaw Conference

* Reuters is not responsible for the content in this press release.

Tue May 20, 2008 8:11am EDT 

STOCKHOLM, Sweden--(Business Wire)--
Regulatory News:

   Medivir (STO:MVIRB) has participated in, and was today presented
before, the Acumen BioFin Rodman & Renshaw 5th Annual Healthcare
Conference in Monaco. The presentation provides an update on Medivir's
projects, including the newly signed deal with Tibotec on HCV
polymerase inhibitors.

   The presentation is now available on Medivir's website under the
Investor&Media/Latest events tab.

   For more on Medivir, please see the company website:
www.medivir.se

   This information was brought to you by Cision
http://newsroom.cision.com

Medivir
Rein Piir, CFO & VP Investor Relations, +46 708 537 292

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.